8-37766296-C-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PP5_Very_Strong
The NM_007198.4(PLPBP):c.260C>T(p.Pro87Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000634 in 1,609,148 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_007198.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLPBP | NM_007198.4 | c.260C>T | p.Pro87Leu | missense_variant | Exon 4 of 8 | ENST00000328195.8 | NP_009129.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152100Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000202 AC: 5AN: 247412Hom.: 0 AF XY: 0.00000747 AC XY: 1AN XY: 133830
GnomAD4 exome AF: 0.0000666 AC: 97AN: 1457048Hom.: 0 Cov.: 30 AF XY: 0.0000662 AC XY: 48AN XY: 724842
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152100Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74280
ClinVar
Submissions by phenotype
not provided Pathogenic:2
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29689137, 28914444, 28391250, 27912044, 33766999, 33728241, 36007526, 33425341) -
This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 87 of the PROSC protein (p.Pro87Leu). This variant is present in population databases (rs755946598, gnomAD 0.008%). This missense change has been observed in individual(s) with clinical features of pyridoxine-dependent epilepsy (PMID: 27912044, 28391250, 29689137, 33766999). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 374856). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt PROSC protein function with a negative predictive value of 80%. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on PROSC function (PMID: 27912044, 29689137). For these reasons, this variant has been classified as Pathogenic. -
Epilepsy, early-onset, vitamin B6-dependent Pathogenic:2
This variant has been previously reported as compound heterozygous change and as homozygous change in patients with Epilepsy, early-onset, vitamin B6-dependent (PMID: 27912044, 28391250). Based on complementation studies in PROSC-deficient E. coli the p.Pro87Leu protein appeared to retained some function (PMID: 27912044). Additional functional studies in bacteria showed that the p.Pro87Leu variant results in decreased protein solubility (PMID: 29689137). It is present in the heterozygous state in the gnomAD population database at a frequency of 0.003% (7/278808) and is absent in the homozygous state, thus is presumed to be rare. In silico tools used to predict the effect of this variant on protein function yield discordant results. Based on the available evidence, the c.260C>T (p.Pro87Leu) variant is classified as Likely Pathogenic. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at